Target intelligence / Profile preview

5'-AMP-activated protein kinase holoenzyme containing the beta-1 regulatory subunit (AMPK-beta1) (AMPK-beta1)

Target
AMPK-beta1
Molecular classification
Enzyme, Serine/threonine protein kinase, Heterotrimeric protein complex
01

Overview

5'-AMP-activated protein kinase (AMPK) is a heterotrimeric enzyme complex consisting of alpha, beta, and gamma subunits that serves as a master regulator of cellular energy homeostasis (Hardie et al., 2012; Nat Rev Mol Cell Biol). The holoenzyme containing the beta-1 regulatory subunit (PRKAB1) is of particular therapeutic interest due to its high expression in the liver and its role in mediating the effects of specific small-molecule activators (UniProt P80331). The beta-1 subunit contains a carbohydrate-binding module (CBM) that, together with the alpha-subunit kinase domain, forms the Allosteric Drug and Metabolite (ADaM) site (Hawley et al., 2012; Science). Activation of beta-1-containing AMPK complexes promotes catabolic processes such as fatty acid oxidation and glucose uptake while suppressing anabolic pathways like lipogenesis and gluconeogenesis (Cool et al., 2006; Cell Metab). Consequently, this target is being actively investigated for the treatment of metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH). Drugs like salicylate and synthetic activators like A-769662 specifically target the beta-1 subunit to enhance AMPK activity and improve metabolic health (Myers et al., 2017; Science). This subunit-specific targeting is thought to offer a therapeutic window by focusing activity on metabolic tissues while potentially avoiding cardiac side effects associated with other isoforms.

Other names
AMPK beta-1PRKAB1-containing AMPK5'-AMP-activated protein kinase subunit beta-1AMPK beta-1 complexAMP-activated protein kinase beta-1
02

Mechanism of action

Direct allosteric activation via binding to the Allosteric Drug and Metabolite (ADaM) site, which is formed by the interface of the alpha-subunit kinase domain and the beta-subunit carbohydrate-binding module (Hawley et al., 2012; Science). This binding also protects the alpha-subunit Thr172 from dephosphorylation by protein phosphatases (Hunter et al., 2014; Chem Biol).

03

Biological functions

Energy homeostasisGlucose metabolismLipid metabolismAutophagyMitochondrial biogenesisFatty acid oxidation
04

Disease associations

Type 2 diabetesNonalcoholic steatohepatitis (NASH)ObesityCardiovascular diseaseMetabolic syndrome
05

Safety considerations

Potential for cardiac hypertrophy (though beta-1 selectivity is intended to reduce this risk compared to beta-2 or pan-activators)Gastrointestinal side effectsPotential for off-target effects on other kinases
06

Interacting drugs

Salicylate

4 more in the full profile.

07

Biomarkers

Phospho-AMPK (Thr172)Phospho-Acetyl-CoA Carboxylase (pACC)Blood glucoseHbA1cLiver fat content

Beyond the preview

Go deeper on 5'-AMP-activated protein kinase holoenzyme containing the beta-1 regulatory subunit (AMPK-beta1) (AMPK-beta1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5'-AMP-activated protein kinase holoenzyme containing the beta-1 regulatory subunit (AMPK-beta1) (AMPK-beta1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call